This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Sun Pharma Advanced Research Company Limited. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2026
Title: Innovations by Malay Shah in Pharmaceutical Composition
Introduction
Malay Shah is a notable inventor based in Vadodara, India. He has made significant contributions to the field of pharmaceuticals, particularly in the stabilization of hydrolytically unstable compounds. His work has implications for the treatment of neonatal seizures, showcasing his commitment to advancing medical science.
Latest Patents
Malay Shah holds 2 patents related to the stabilization of phenobarbital sodium for injection. His latest patents focus on a lyophilized pharmaceutical composition that ensures the stability of phenobarbital or its salts. The compositions are designed to be reconstituted into an aqueous solution for injection, maintaining an ethanol content between 5000 ppm and 70000 ppm. Notably, these compositions demonstrate stability for up to two years, with total impurities not exceeding 0.5%. This innovation is particularly beneficial for treating neonatal seizures.
Career Highlights
Malay Shah is associated with Sun Pharma Advanced Research Company Limited, where he continues to contribute to pharmaceutical research and development. His expertise in creating stable pharmaceutical formulations has positioned him as a valuable asset in the industry.
Collaborations
He has collaborated with colleagues such as Ravi Patel and Bhushan Borole, working together to enhance the efficacy and safety of pharmaceutical products.
Conclusion
Malay Shah's innovative work in pharmaceutical compositions highlights his dedication to improving medical treatments. His patents reflect a significant advancement in the stability of critical medications, ultimately benefiting patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
